Kepler Capital Sticks to Their Buy Rating for Grifols SA (GRFS)
In a report released on July 27, Pablo de Renteria from Kepler Capital maintained a Buy rating on Grifols SA (GRFS – Research Report), wi...
Source: businessinsider.com
Diagnostic Segment News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Diagnostic Segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Diagnostic Segment Today - Breaking & Trending Today
Stevanato Group S.p.A.: Stevanato Group Announces Second Quarter 2021 Financial Results
- Establishes Full Year 2021 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology
Source: finanznachrichten.de